Answers are grounded in this paper and cite their sources.
To evaluate the safety of deutetrabenazine in treating tardive dyskinesia (TD) and chorea associated with Huntington’s disease (HD).
No takes yet. Share an insight, caveat, or question.
Anderson et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: